ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.970
+0.030 (1.02%)
At close: Aug 13, 2025, 4:00 PM
3.000
+0.030 (1.01%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $48.27 million as of August 14, 2025. Its market cap has increased by 495.87% in one year.
Market Cap
48.27M
Enterprise Value
49.40M
1-Year Change
495.87%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $48.27M, a decrease of -39.29%. That is a compound annual growth rate of -11.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 49.30M | 540.26% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |